(redirected from Cancer cachexia)
Also found in: Dictionary, Medical, Encyclopedia.
Related to Cancer cachexia: paraneoplastic syndrome
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for cachexia

any general reduction in vitality and strength of body and mind resulting from a debilitating chronic disease

References in periodicals archive ?
The report provides a snapshot of the global therapeutic landscape of Cancer Cachexia
The high incidence and mortality rates of cancer cachexia attract much attention in recent years (Morley et al.
PsiOxus), a development stage biotechnology company, has completed patient enrollment for its Phase II clinical trial to study MT-102, a small molecule therapeutic for the treatment of cancer cachexia.
Many strong studies now demonstrate that the carnitine supplements can reduce the rate and severity of cancer cachexia.
Kumar and colleagues suggest that eicosapentaenoic acid (EPA) might be helpful in preventing and treating cancer cachexia.
Cancer cachexia impairs quality of life and response to therapy, increasing morbidity and mortality of cancer patients.
The current scientific consensus is that cancer cachexia results primarily from an underlying metabolic imbalance induced by the cancer, causing the body's metabolism to speed up," explains Keith Block, medical director of the Block Center for Integrative Cancer Care, Evanston, Ill.
The Cancer Cachexia guidelines were developed by an expert group of Australian dietitians experienced in the area (Cancer Cachexia Steering Committee).
Cancer cachexia is commonly associated with advanced or late-stage cancer.
Specific cancer studies include: multiple myeloma, leukemia, glioblastoma, renal cancer, cancer cachexia and colorectal cancer.
Objective: Cancer cachexia is a life-threatening syndrome characterized by severe body weight loss, due to depletion of adipose tissue and skeletal muscle, and affects up to 80% of patients with advanced cancers.
Thus, the management of cancer cachexia is primordial to achieve a successful treatment.
Kumar and Hindi believe their research ultimately will lead to improved treatments for muscle wasting diseases such as muscular dystrophy, ALS, cancer cachexia, diabetes, heart disease and others.
Cancer Cachexia - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
MT-102 is the most advanced product and is in mid-stage clinical trials for the treatment of cancer cachexia and the company's second product, ColoAd1, is an oncolytic virus that is scheduled to enter clinical trials in 2012.
Full browser ?